Page last updated: 2024-11-06

triethylenemelamine and Adenocarcinoma, Bronchiolo-Alveolar

triethylenemelamine has been researched along with Adenocarcinoma, Bronchiolo-Alveolar in 1 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Adenocarcinoma, Bronchiolo-Alveolar: A carcinoma derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CLARKSON, B1

Other Studies

1 other study available for triethylenemelamine and Adenocarcinoma, Bronchiolo-Alveolar

ArticleYear
RELATIONSHIP BETWEEN CELL TYPE, GLUCOSE CONCENTRATION, AND RESPONSE TO TREATMENT IN NEOPLASTIC EFFUSIONS.
    Cancer, 1964, Volume: 17

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adolescent; Alkylating Agents; Antimetabolites; Antineoplastic

1964